Is Brigatinib available in China?

Brigatinib/The original drug Brigatinib is sold in China. Brigatinib tablets have been launched for sale in China in 2022. It is a cancer drug used to treat adults with a type of non-small cell lung cancer (NSCLC). It is used for patients who have not previously been treated with ALK inhibitor drugs or who have previously been treated with the ALK inhibitor crizotinib. It only treats non-small cell lung cancer with brigatinib if it is "ALK positive." After being launched in China, brigatinib has also entered the category of Class B medical insurance, and patients who meet the indications can use medical insurance for reimbursement.